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Frequency of lower Ureteric Stones and Their
Treatment by Tamsulosin, Aden
Ali Ahmed Salem Hatroom*
Abstract
The aim of the study is to find out the frequency of lower ureteric stones related to sex, age, and the outcome of using
tamsulosin in their treatment This was a retrospective study of all patients who suffer from lower ureteral stone and
seen in our Private Urology Clinic from January 2014 to December 2017 in Aden. The total patients were 160. They
were 98 (61.3%) males and 62 (38.7%) females) with ratio male to female 1.6 :1. The mean age of patients is (35.2 ±
11.2) years, range (15 to 56) years. Most involved side is left ureter 80 (50.0%). The mean size of stones is 6.8 ± 1.6
mm. The most effected age group was 21 – 50 years with 76.3%. Seventy four (46.3%) of the patients treated only
with Tamsulosin and the expulsion time ≤ 9 days were in 20(12.5%) of the patients while > 9 days were in 54(33.8%)
patients. Patients treated by Tamsulosin with prednisolone were less in the expulsion time of stones ≤ 9 days. By the
size of ≤ 7 mm, 38(23.7%) of patients have expelled the stones in the time ≤ 9 days and 66(41.3%) of the patients
expelled the stones in the time > 9 days. Also, by the size of > 7 mm, only 10(6.3%) of patients have expelled the
stones in time ≤ 9 days and 46(28.7%) expelled the stones in time > 9 days, (p = 0.010). We concluded that
tamsulosin is an effective and safe treatment modality for lower ureteral stones of less than ≤10 mm.
Key words: Frequency, lower ureter, stone, treatment, tamsulosin .

Introduction:
Ureteral stones are a common problem in
primary care practice ]9[, with observed
incidences of 3%~18% in various geographical
locations ]22[.
The ureteral stones are most prevalent between
the ages of 20 and 40 years and are three times
greater in men than women ]16[. Women
typically excrete more citrate and less calcium
than men, which may explain the higher
incidence of stone diseases in men ]11[.
The location and the size of the stone, the
availability of the technology, the treatment cost,
the experience of the surgeon, and the preference
of the patients are considered when a treatment is
chosen among the other alternatives ]2[. The
probability of spontaneous expulsion of the
ureteral calculi has two factors: the size of the
calculi and the anatomic location of the calculi.
Therefore, spontaneous expulsion of the stone
protects the patient from surgical intervention,
anesthesia risk and additional costs, who does
not have infection history and who has pain
control and small size of calculi. By this way,
with the understanding of the ureter physiology
in detail, the concept of medical expulsive
therapy has been developed in order to make the
spontaneous expulsion of the stone easier ]23[.
The purpose of the medical expulsive therapy is to
increase the spontaneous probability of the stone
expulsion by enabling relaxation in the ureter
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smooth muscle structure and eventually it reduces
the pain level and frequency felt by the patient,
shorten the time of stone expulsion, reduces the
need of operation, prevents the risk and
complications related with the operation and
reduces the cost of the treatment. Some main
points need attention during the medical expulsive
treatment. The most important two factors of them
are the location of the calculi in the ureter and the
size of the calculi. The maximum upper limit
recommended for the treatment of the medical
expulsive is 10 mm ]24[.
The management of ureteral stones includes
watchful waiting for spontaneous passage,
medical expulsive treatment, extracorporeal
shock wave lithotripsy, ureterorenoscopic
lithotripsy,
open
ureterolithotomy
and
laparoscopic ureterolithotomy. Except watchful
waiting and medical expulsive treatment, the
other interventions have higher healthcare
expenditures and are relatively invasive, so the
medical expulsive treatment is preferred by
patients, as it might facilitate the spontaneous
expulsion of ureteral stones ]20[.
Several pharmacological agents are used in
medical expulsive treatment, including αblockers, calcium channel antagonists, phosphordiesterase inhibitors, and corticosteroids. These
have been demonstrated to facilitate ureteral
stone passage. Of these interventions, α-blockers
have the highest ranking, and the most
commonly used α-blocker is tamsulosin ]17[.
Objective:
To find out the frequency of lower ureteric
stones related to sex, age, and the outcome of
using tamsulosin in their treatment
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Materials and method:
A retrospective study of all patients who suffer
from lower ureteral stone and seen in our Private
Urology Clinic in Al-Mansoura, Aden over a 4years-period, from January 2014 to December
2017.
During this period, a total of 160 patients were
found with lower ureteric stones.
The patients' charts were retrieved and obtained
information about sex, age, residency, stone side,
stone size, type of treatment, and expulsion time
of stone.
The data was entered into a computer and
analyzed using SPSS version 17, statistical
package. For variables difference, chi-square tests,
and P values were calculated, with differences at
less than 5% level being regarded as significant.
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Results:
During the four years study period, 160 patients
diagnosed with lower ureteric stones in our private
clinic. They were 98 (61.3%) males and 62
(38.7%) females with ratio male to female 1.6 :1.
The mean age of all patients was (35.2 ± 11.2)
years, range (15 to 56) years, (33.6 ± 10.6 years)
for males, and (37.6 ± 11.6 years) for females,
(Table 1 & Figure 1).
Most of the patients were from rural areas
108(67.5%).
The predominant stone sides involved were in
the left ureter 80 (50.0%), followed by the right
ureter 54(33.8%) while the bilateral sides were
26 (16.2%). The stone size ranges from 5mm to
10 mm and the mean size is 6.8 ± 1.6 mm.

38.7
Males
Females
61.3

Figure 1: Distribution of patients related to sex
Table 1: Distribution of ratio, means and variables frequency of study patients
Items
Sex:
Male
Female
Ratio male to female
Age (Range 15 - 56 years):
Mean age of all patients ± SD (years)
Mean age of males ± SD
Mean age of females ± SD
Residency:
Urban
Rural
Stone side:
Left ureter
Right ureter
Bilateral
Stone size (Range 5mm – 10 mm):
Mean size ± SD (mm)
Expulsion time of stone: (Range 7–14 days)
Mean ± SD (days)

SD: standard deviation

2

Mean

No

%

98
62

61.3
38.7

52
108

32.5
67.5

80
54
26

50.0
33.8
16.2

1.6 :1
35.2 ± 11.2
33.6 ± 10.6
37.6 ± 11.6

6.8 ± 1.6
10.5 ± 2.8
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Table 2 shows that most effected age group was
21 – 50 years with 76.3% followed by the age
group ≤ 20 years 12.5% then the age group > 50
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years with 11.2% and they were in both sex
predominance. The difference between values
was not statically significant (p > 0.05).

Table 2: Distribution of patients with lower ureteric stones related to age group
Age group (years)

Sex
Male

No
≤ 20
16
21 – 30
20
31 – 40
34
41 – 50
20
> 50
8
Total
98
Chi-square = 8.643 ; p-value > 0.05

(%)
(10.0)
(12.5)
(21.3)
(12.5)
(5.0)
(61.3)

Table 3 and Figure 2 show the treatment types
and the expulsion time of stones. Seventy four
(46.3%) of the patients treated only with
Tamsulosin and the expulsion time ≤ 9 days were
in 20(12.5%) of the patients while > 9 days were
in 54(33.8%) patients.
Patients treated by Tamsulosin with prednisolone
were less in the expulsion time of stones ≤ 9
days; they represented 24(15.0%). The difference
between values is not statistically significant (p >
0.05).

Total
Female
No
(%)
4
(2.5)
16
(10.0)
14
(8.7)
18
(11.3)
10
(6.2)
62
(38.7)

No
20
36
48
38
18
160

(%)
(12.5)
(22.5)
(30.0)
(23.8)
(11.2)
(100)

The table 3 illustrates also the expulsion time
related to the size of stones. By the size of ≤ 7
mm, 38(23.7%) of patients have expelled the
stones in the time ≤ 9 days and 66(41.3%) of the
patients expelled the stones in the time > 9 days.
Also, by the size of > 7 mm, only 10(6.3%) of
patients have expelled the stones in time ≤ 9 days
and 46(28.7%) expelled the stones in time > 9
days. The difference between values is
statistically highly significant (p = 0.010).

Table 3: Expulsion time of stones related to treatment types and the size of stone
Variables of medication & size

Expulsion time of stone (days)
≤ 9 days
No
(%)

Treatment:
Tamsulosin
Tamsulosin with prednisolone
Tamsulosin with antibiotic
Total
Size (mm):
≤7
>7
Total
Millimeters = mm;

> 9 days
No
(%)

No

Total
(%)

20
24
4
48

(12.5)
(15.0)
(2.5)
(30.0)

54
40
18
112

(33.8)
(25.0)
(11.2)
(70.0)

74
64
22
160

(46.3)
(40.0)
(13.7)
(100.0)

38
10
48

(23.7)
(6.3)
(30.0)

66
46
112

(41.3)
(28.7)
(70.0)

104
56
160

(65.0)
(35.0)
(100)

P-value

P > .05

P = 0.010
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46.3
40

13.7

Tamsulosin

Tamsulosin with
prednisolone

Tamsulosin with
antibiotic

Figure 2: Distribution of treatment types
Discussion:
Symptomatic ureteric calculi represents the most
common condition encountered by a urologist in
an emergency setting ]14[. Among all ureteral
stones, 70% are found in the lower third of the
ureter ]11[. The goal of the surgical treatment of
patients suffering from ureteral calculi is to
achieve complete stone clearance with minimal
morbidity ]15[.
In the present study, we found a total of 160
patients were diagnosed with lower ureteral
stones according to their medical records. Males
were significantly more affected than females;
they were 98(61.3%) males and 62(38.7%)
females with the ratio of males to females 1.6:1.
Pradhan et al ]19[ and Trinchieri ]27[ reported
that the prevalence of urolithiasis varies
according to the geography, race/ethnicity,
climate, gender, age and occupation.
Dong-Un, et al (8) mentioned that the prevalence
in China is yet to be determined life time
prevalence is estimated at 10% to 15%. It is
afflicting 13% of men and 7% of women ]11[.
Symptomatic ureterolithiasis is one of the
important issues that the urologists face in
emergency clinical settings. Of all urinary tract
stones, 20% are ureteral stones, and 70% of these
ureteral stones are located in the distal portion of
the ureters ]29[.
The frequency of occurrence of ureteric stones
in a population and the type of ureteric stone
may vary with the ethnicity. This may be
attributed to the dietary pattern and changes in
the climate and environment ]25[.

4

In the current study we found the mean age of all
patients was (35.2 ± 11.2) years, range (15 to 56)
years, (33.6 ± 10.6 years) for males, and (37.6 ±
11.6 years) for females,
Also, we found that most effected age group was
21 – 50 years with 76.3% followed by the age
group ≤ 20 years 12.5% then the age group > 50
years with 11.2% and they were in both males and
females predominance. The difference between
values was not statically significant (p > 0.05).
Jeevaraman et al ]12[ reported in their study in
India that the peak age incidence of ureteric
calculi was found in the age group of 21-49 years
and the male to female ratio was 1.7:1.
Also, there are other published studies found the
same findings to our mentioned results of mean
age and most effected age group ]5,13,18[.
In our current study the predominant stone sides
involved were in the left ureter 80 (50.0%),
followed by the right ureter 54(33.8%) while the
bilateral sides were 26 (16.2%).
Degaonkar et al ]5[ found in their study in India
that the left side of ureter more involved of lower
ureter stones by 55%.
Our study revealed that the stones size range
from 5mm to 10 mm and the mean size is 6.8 ±
1.6 mm. Other published studies reported to
some extent similarly results as ours ]1,4,13[.
We found in our study 74 (46.3) of the patients
treated only with Tamsulosin and the expulsion
time ≤ 9 days were in 20(12.5%) of the patients
and expulsion time with > 9 days were in
54(33.8%) patients.
The patients treated by Tamsulosin with
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prednisolone were less in the expulsion time of
stones ≤ 9 days; they represented 24(15.0%). The
difference between values is not statistically
significant (p > 0.05).
Prednisolone drug in association with tamsulosin
seemed to induce more rapid stone expulsion ]6[.
Thapa et al ]26[ mentioned that due to the more
adverse effect of other drugs, the use of alphablockers has increased recently, in which it was
observed that tamsulosin is a safe and effective
drug that enhances spontaneous passage of distal
ureteral stones sized less than 10 mm.
The human ureter contains predominantly alpha
receptors which are further classified as alpha 1
and alpha 2 receptors. In turn alpha 1 receptors,
which are divided into subtypes on the basis of
their selectivity. Alpha 1a (proximal urethra,
prostate, bladder outlet), alpha1b (smooth
muscles of vessels) and alpha1d (detrusor, lower
ureter) ]3[. When stimulated, they inhibit the
basal tone, peristaltic wave frequency and the
ureteral contractions even in the intramural part
of lower ureter. They may work on the
obstructed ureter by inducing an increase in the
intraureteral pressure gradient around the stone,
which increase in the urine bolus above the stone
as well as decreased peristalsis below the ureter,
in association with the decrease in basal and
micturition pressures even at the bladder neck,
thereby an increased chance of stone expulsion
]21[. Ukhal and co-workers were the first to
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report positive result in accelerating the lower
ureteral stone passage using alpha blocker agent
]28[. De Sio et al published a study of 96 patients
and achieved 90% expulsion rate with tamsulosin
therapy ]7[. Griwan et al, noticed overall stone
expulsion rate of 21 out of 30 patients (70%) was
observed for control group and 27 out of 30
patients (90%) in study group ]10[.
Cervenakov et al ]3[, concluded that the
treatment by α1 blockers considerably decreased
not only lower urinary tract symptoms but also
helped to accelerate the passing of minor calculi
from the terminal parts of the ureter of 80.4% of
patients.
Dellabella et al ]6[, used tamsulosin as a
spasmolytic drug during episodes of ureteral
colic due to juxtavesical calculi, observed an
increased stone expulsion rate and with a
decrease in stone expulsion time, the need for
hospitalization and endoscopic procedures.
Similar results were reported by other published
studies ]4,5,12[.
Conclusion:
Tamsulosin is an effective and safe treatment
modality for lower ureteral stones of less than
≤10 mm. The tamsulosin has been found to
increase and hasten stone expulsion rates,
decrease acute attacks by acting as a spasmolytic,
reduces mean days to stone expulsion and
decreases analgesic dose usage. Further
researches in this filed are recommended.
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تىاتر أحجار احلالب األسفل وعالجها بىساطة تامسىلىسني  ،عدن
عمي أحمد سالم حطروم
الممخص
الهدف من الدراسة هو معرفة تواتر الحجارة البولية في الحالب األسفل وفقا لمجنس والعمر ونتائج استخدام تامسولوسين في عالجها كانت
الدراسة عبارة عن دراسة استرجاعية لجميع المرضى الذين يعانون من أ حجار الحالب األسفل وتمت معاينتهم في عيادة المسالك البولية
الخاصة من يناير  2014إلى ديسمبر  2017في عدن .تم تشخيص  160مريضا بأحجار الحالب األسفل وكانوا  )% 61.3( 98من
الذكور و  )% 38.7( 62من اإلناث مع نسبة الذكور إلى اإلناث  .1 :1.6متوسط عمر المرضى ( )11.2 ± 35.2سنة  ,المدى (15
إلى  )56سنة .وكانت غالبية اإلصابة في الحالب األيسر  .)% 50.0( 80متوسط حجم األحجار هو  1.6 ± 6.8مم .وكانت الفئة
العمرية األكثر تأث اًر هي  50 - 21سنة بنسبة .% 76.3أربعة وسبعون ( )%46.3من المرضى الذين عولجوا فقط بوساطة تامسولوسين

بمغت الفترة حتى إخراج الحجر ≤  9أيام وكانت في  )% 12.5( 20من المرضى بينما كانت >  9أيام في  )% 33.8( 54من
المرضى .إن المرضى الذين عولجوا بوساطة تامسولوسين مع بريدنيزولون كانوا األقل في الفترة الزمنية ≤  9أيام .وبالنسبة لمقياس
الحجر ≤  7مم  ,فإن  )%23.7( 38من المرضى تخمص من الحجارة في زمن ≤  9أيام و  )%41.3( 66من المرضى تخمصوا من
الحجارة في زمن >  9أيام .أيضا  ,واألحجار مقاس >  7ممم  ,طرد فقط  )% 6.3( 10من الحجارة في الزمن المحدد ≤  9أيام و 46
( )% 28.7طرد األحجار في الزمن المناسب >  9أيام  .)P = 0.010( ,نستنتج أن تامسولوسين هو عالج فعال وآمن لألحجارفي
الحالب األسفل وذات قياس ≤  10ممم.
الكممات المفتاحية :تردد  ,حالب أسفل  ,أحجار  ,معالجة  ,تامسولوسين
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